Adding a Gut-Liver Targeted Metabolic Modulator Using Novel Inflammatory Pathways for Increased Metabolic Benefits
Time: 2:00 pm
day: Day One
Details:
- Targeting novel inflammatory pathways within the gut-liver axis presents a promising strategy for developing innovative metabolic modulators
- Leveraging these modulators in combination with existing therapies, such as GLP-1 receptor agonists, to offer enhanced metabolic benefits, including improved weight loss, glycemic control, and reduced hepatic steatosis
- Providing a treatment with better ease of patient use for better weight maintenance
